Analystreport

Cidara Therapeutics, Inc. (NASDAQ: CDTX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "sell" rating.

Cidara Therapeutics, Inc.  (CDTX) 
Last cidara therapeutics, inc. earnings: 3/4 05:55 am Check Earnings Report
US:NASDAQ Investor Relations: ir.cidara.com